Anti-Inflammatory Therapy in Chronic Disease: Challenges and Opportunities

@article{Tabas2013AntiInflammatoryTI,
  title={Anti-Inflammatory Therapy in Chronic Disease: Challenges and Opportunities},
  author={Ira A Tabas and Christopher K. Glass},
  journal={Science},
  year={2013},
  volume={339},
  pages={166 - 172}
}
A number of widespread and devastating chronic diseases, including atherosclerosis, type 2 diabetes, and Alzheimer’s disease, have a pathophysiologically important inflammatory component. In these diseases, the precise identity of the inflammatory stimulus is often unknown and, if known, is difficult to remove. Thus, there is interest in therapeutically targeting the inflammatory response. Although there has been success with anti-inflammatory therapy in chronic diseases triggered by primary… 

Anti-inflammatory and Immunomodulatory Therapies in Atherosclerosis.

TLDR
This chapter aims to give an overview of current advances in immunomodulatory treatment approaches for atherosclerotic cardiovascular diseases.

Inflammation-responsive delivery systems for the treatment of chronic inflammatory diseases

TLDR
Recent advances in the development of anti-inflammatory DDSs with built-in pathological inflammation-specific responsiveness for the treatment of chronic inflammatory diseases are summarized.

The multifaceted link between inflammation and human diseases

TLDR
The aim of this review was to focus on advances in the understanding of chronic inflammation and to summarize the impact and involvement of inflammatory agents in certain human diseases.

Bioresponsive drug delivery systems for the treatment of inflammatory diseases

Pro-resolution therapeutics for cardiovascular diseases.

Epigenetics of chronic inflammatory diseases

TLDR
The significance of defining the contribution of epigenetic defects to nonresolving inflammation and aging, each associated with these diseases, is highlighted, as these are likely to provide new insights into inflammatory disease pathogenesis.

Immunomodulatory effect of specialised pro-resolving mediators in humans

TLDR
This thesis demonstrates that in humans, effect of SPMs, at physiological doses, may be limited only to enhancing neutrophil clearance and shows that orally active SPM inducing molecule, JBT-101, at doses currently being employed in phase II clinical trials, has a potent anti-inflammatory effect.

Engineering autoreactive T and B cell responses toward active immunotherapy for inflammatory diseases

TLDR
An alternative active immunotherapy approach that incorporates an engineered fragment of complement protein C3dg and peptide epitopes derived from the soluble form of TNF into a self-assembled supramolecular nanofiber platform able to codisplay different proteins in a controlled and modular manner is developed.

STUDY ON ANTI-INFLAMMATORY THERAPY IN CHRONIC DISEASES, ITS HOPES AND CHALLENGES IN A TERTIARY CARE TEACHING HOSPITAL

TLDR
Though these anti-inflammatories are of great help in arresting inflammation and pain, their use must be tempered according to the need with the realization that they can cause potential harm.

1,8-cineole: An Underappreciated Anti-inflammatory Therapeutic

TLDR
It is argued that use of 1,8-cineole as an anti-inflammatory agent needs greater study in other diseases with a chronic inflammatory component, including atherosclerotic cardiovascular disease, type 2 diabetes mellitus, and arthritic complications.
...

References

SHOWING 1-10 OF 72 REFERENCES

Fibroblasts as therapeutic targets in rheumatoid arthritis and cancer.

TLDR
An increasing body of evidence implicates rheumatoid arthritis synovial fibroblasts in driving the persistent, destructive characteristics of the disease and their role as therapeutic targets is explored.

Metabolic Syndrome, Insulin Resistance, and Roles of Inflammation – Mechanisms and Therapeutic Targets

Obesity and its comorbidities, including type 2 diabetes mellitus and cardiovascular disease, are associated with a state of chronic low-grade inflammation that can be detected both systemically and

Autoimmunity in atherosclerosis: a protective response losing control?

TLDR
Observations point to the possibility of developing new treatments for atherosclerosis based on modulation of immune responses against plaque antigens, an approach presently tested clinically for several other chronic inflammatory diseases with autoimmune components.

Immunomodulatory therapies in sepsis

TLDR
It is demonstrated that sepsis shows a biphasic immunological pattern during the initial and later phase: the early hyperinflammatory phase is counterbalanced by an anti-inflammatory response which may lead to a hypoinflammatory state.

Update on statin-mediated anti-inflammatory activities in atherosclerosis

TLDR
Evidence on statin-mediated regulation of inflammatory pathways in atherogenesis is updated and it is shown thatinflammatory intracellular pathways involving kinase phosphorylation and protein prenylation are modulated by statins.

Attenuation of neuroinflammation and Alzheimer's disease pathology by liver x receptors

TLDR
It is shown that endogenous LXR signaling impacts the development of AD-related pathology and is proposed that LXRs may be tractable targets for the treatment of AD due to their ability to modulate both lipid metabolic and inflammatory gene expression in the brain.

Progress and challenges in translating the biology of atherosclerosis

TLDR
Understanding how to combine experimental and clinical science will provide further insight into atherosclerosis and could lead to new clinical applications.

Multimodal clinical imaging to longitudinally assess a nanomedical anti-inflammatory treatment in experimental atherosclerosis.

TLDR
This study evaluates a powerful two-pronged strategy for efficient treatment of atherosclerosis that includes nanomedical therapy of Atherosclerotic plaques and the application of noninvasive and clinically approved imaging techniques to monitor delivery and therapeutic responses.

Protective role of interleukin-10 in atherosclerosis.

TLDR
It is shown that IL-10-deficient C57BL/6J mice fed an atherogenic diet and raised under specific pathogen-free conditions exhibit a significant 3-fold increase in lipid accumulation compared with wild-type mice, which underscores the critical roles ofIL-10 in both atherosclerotic lesion formation and stability.
...